Defence Therapeutics Inc.

Defence Therapeutics is a Canadian Biotech developing next generation biopharmaceutical innovations for various immuno-oncology (IO) and infectious diseases (ID) indications.

Company Feed

Defence Therapeutics: Revolutionizing Immune-Related Therapies with ACCUM Technology
May 3, 2023

Defence Therapeutics: Revolutionizing Immune-Related Therapies with ACCUM Technology

Defence Therapeutics is a Canadian biotech company developing immune-related therapies using their proprietary ACCUM technology.

This is some text inside of a div block.
Defence Therapeutics: Developing Immune-related Therapies for Cancer Treatment
April 19, 2023

Investor Alert - Defence Therapeutics: Developing Immune-related Therapies for Cancer Treatment

Defence Therapeutics is a Canadian biotech company developing immune-related therapies for cancer treatment, including cancer vaccines, antibodies, and drug delivery vehicles.

This is some text inside of a div block.
Defence Therapeutics: Developing Next Generation Therapies to Combat Cancer with Propietary ACCUM™ Technology
January 2, 2023

Defence Therapeutics: Developing Next Generation Therapies to Combat Cancer with Propietary ACCUM™ Technology

Cancer treatment along with other infectious diseases need clinical solutions and this company may have one. BTV interviews Defense Therapeutics to learn about their proprietary ACCUM™ technology and its proven ability to deliver treatment drugs to diseased cells.

This is some text inside of a div block.
Defence Therapeutics
October 26, 2022

Defence Therapeutics: Making a Global Impact

Defence Therapeutics is a Canadian Biotech company developing next generation bio-pharmaceutical innovations for various immuno-oncology (IO) and infectious diseases (ID) indications.

This is some text inside of a div block.
Defence Therapeutics
October 26, 2022

Defence Therapeutics: Developing Next Generation Biopharmaceutical Innovations

Defence Therapeutics is a publicly-traded biotechnology company working on engineering the next generation vaccines and ADC products using its proprietary platform.

This is some text inside of a div block.
Subscribe and receive the investor Info